Compass Therapeutics, Inc. (CMPX)
Nasdaq: CMPX · CIK 0001738021 · United States
Every official Compass Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open CMPX filings
Compass Therapeutics, Inc. documents
- Compass Therapeutics, Inc. 10-K 2026CMPX 10-K 2026: annual report for fiscal 2026
- Compass Therapeutics, Inc. 10-K 2025CMPX 10-K 2025: annual report for fiscal 2025
- Compass Therapeutics, Inc. 10-K 2024CMPX 10-K 2024: annual report for fiscal 2024
- Compass Therapeutics, Inc. 10-K 2023CMPX 10-K 2023: annual report for fiscal 2023
- Compass Therapeutics, Inc. 10-K 2022CMPX 10-K 2022: annual report for fiscal 2022
- Compass Therapeutics, Inc. 10-Q 2026CMPX 10-Q 2026: quarterly report for fiscal 2026
- Compass Therapeutics, Inc. 10-Q 2025CMPX 10-Q 2025: quarterly report for fiscal 2025
- Compass Therapeutics, Inc. 10-Q 2024CMPX 10-Q 2024: quarterly report for fiscal 2024
- Compass Therapeutics, Inc. 10-Q 2023CMPX 10-Q 2023: quarterly report for fiscal 2023
- Compass Therapeutics, Inc. 10-Q 2022CMPX 10-Q 2022: quarterly report for fiscal 2022
- Compass Therapeutics, Inc. 8-K 2026CMPX 8-K 2026: current report for fiscal 2026
- Compass Therapeutics, Inc. 8-K 2025CMPX 8-K 2025: current report for fiscal 2025
- Compass Therapeutics, Inc. 8-K 2024CMPX 8-K 2024: current report for fiscal 2024
- Compass Therapeutics, Inc. 8-K 2023CMPX 8-K 2023: current report for fiscal 2023
- Compass Therapeutics, Inc. 8-K 2022CMPX 8-K 2022: current report for fiscal 2022
- Compass Therapeutics, Inc. DEF 14A 2026CMPX DEF 14A 2026: proxy statement for fiscal 2026
- Compass Therapeutics, Inc. DEF 14A 2025CMPX DEF 14A 2025: proxy statement for fiscal 2025
- Compass Therapeutics, Inc. DEF 14A 2024CMPX DEF 14A 2024: proxy statement for fiscal 2024
- Compass Therapeutics, Inc. DEF 14A 2023CMPX DEF 14A 2023: proxy statement for fiscal 2023
- Compass Therapeutics, Inc. DEF 14A 2022CMPX DEF 14A 2022: proxy statement for fiscal 2022
- Compass Therapeutics, Inc. Form 4 2026CMPX Form 4 2026: insider trading filing for fiscal 2026
- Compass Therapeutics, Inc. Form 4 2025CMPX Form 4 2025: insider trading filing for fiscal 2025
- Compass Therapeutics, Inc. Form 4 2024CMPX Form 4 2024: insider trading filing for fiscal 2024
- Compass Therapeutics, Inc. Form 4 2023CMPX Form 4 2023: insider trading filing for fiscal 2023
- Compass Therapeutics, Inc. Form 4 2022CMPX Form 4 2022: insider trading filing for fiscal 2022
- Compass Therapeutics, Inc. S-1 2026CMPX S-1 2026: registration statement for fiscal 2026
- Compass Therapeutics, Inc. S-1 2025CMPX S-1 2025: registration statement for fiscal 2025
- Compass Therapeutics, Inc. S-1 2024CMPX S-1 2024: registration statement for fiscal 2024
- Compass Therapeutics, Inc. S-1 2023CMPX S-1 2023: registration statement for fiscal 2023
- Compass Therapeutics, Inc. S-1 2022CMPX S-1 2022: registration statement for fiscal 2022
- Compass Therapeutics, Inc. 13F 2026CMPX 13F 2026: institutional holdings for fiscal 2026
- Compass Therapeutics, Inc. 13F 2025CMPX 13F 2025: institutional holdings for fiscal 2025
- Compass Therapeutics, Inc. 13F 2024CMPX 13F 2024: institutional holdings for fiscal 2024
- Compass Therapeutics, Inc. 13F 2023CMPX 13F 2023: institutional holdings for fiscal 2023
- Compass Therapeutics, Inc. 13F 2022CMPX 13F 2022: institutional holdings for fiscal 2022
More companies